Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

BACKGROUND:Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with a...

Full description

Bibliographic Details
Main Authors: Sylvie Tordjman, George M Anderson, Michel Botbol, Sylvie Brailly-Tabard, Fernando Perez-Diaz, Rozenn Graignic, Michèle Carlier, Gérard Schmit, Anne-Catherine Rolland, Olivier Bonnot, Séverine Trabado, Pierre Roubertoux, Guillaume Bronsard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-08-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2728512?pdf=render
_version_ 1818111473713414144
author Sylvie Tordjman
George M Anderson
Michel Botbol
Sylvie Brailly-Tabard
Fernando Perez-Diaz
Rozenn Graignic
Michèle Carlier
Gérard Schmit
Anne-Catherine Rolland
Olivier Bonnot
Séverine Trabado
Pierre Roubertoux
Guillaume Bronsard
author_facet Sylvie Tordjman
George M Anderson
Michel Botbol
Sylvie Brailly-Tabard
Fernando Perez-Diaz
Rozenn Graignic
Michèle Carlier
Gérard Schmit
Anne-Catherine Rolland
Olivier Bonnot
Séverine Trabado
Pierre Roubertoux
Guillaume Bronsard
author_sort Sylvie Tordjman
collection DOAJ
description BACKGROUND:Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with autism. METHODOLOGY/PRINCIPAL FINDINGS:The study was conducted on 73 children and adolescents with autism and 115 normal individuals matched for age, sex and pubertal stage. Behavioral pain reactivity of individuals with autism was assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and child psychiatrist during blood drawing), and compared to controls during venepuncture. Plasma beta-endorphin concentrations were measured by radioimmunoassay. A high proportion of individuals with autism displayed absent or reduced behavioral pain reactivity at home (68.6%), at day-care (34.2%) and during venepuncture (55.6%). Despite their high rate of absent behavioral pain reactivity during venepuncture (41.3 vs. 8.7% of controls, P<0.0001), individuals with autism displayed a significantly increased heart rate in response to venepuncture (P<0.05). Moreover, this response (Delta heart rate) was significantly greater than for controls (mean+/-SEM; 6.4+/-2.5 vs. 1.3+/-0.8 beats/min, P<0.05). Plasma beta-endorphin levels were higher in the autistic group (P<0.001) and were positively associated with autism severity (P<0.001) and heart rate before or after venepuncture (P<0.05), but not with behavioral pain reactivity. CONCLUSIONS/SIGNIFICANCE:The greater heart rate response to venepuncture and the elevated plasma beta-endorphin found in individuals with autism reflect enhanced physiological and biological stress responses that are dissociated from observable emotional and behavioral reactions. The results suggest strongly that prior reports of reduced pain sensitivity in autism are related to a different mode of pain expression rather than to an insensitivity or endogenous analgesia, and do not support opioid theories of autism. Clinical care practice and hypotheses regarding underlying mechanisms need to assume that children with autism are sensitive to pain.
first_indexed 2024-12-11T03:03:36Z
format Article
id doaj.art-c280f332cfea4feeb2c64aec6f7c29ec
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T03:03:36Z
publishDate 2009-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c280f332cfea4feeb2c64aec6f7c29ec2022-12-22T01:22:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-08-0148e528910.1371/journal.pone.0005289Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.Sylvie TordjmanGeorge M AndersonMichel BotbolSylvie Brailly-TabardFernando Perez-DiazRozenn GraignicMichèle CarlierGérard SchmitAnne-Catherine RollandOlivier BonnotSéverine TrabadoPierre RoubertouxGuillaume BronsardBACKGROUND:Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with autism. METHODOLOGY/PRINCIPAL FINDINGS:The study was conducted on 73 children and adolescents with autism and 115 normal individuals matched for age, sex and pubertal stage. Behavioral pain reactivity of individuals with autism was assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and child psychiatrist during blood drawing), and compared to controls during venepuncture. Plasma beta-endorphin concentrations were measured by radioimmunoassay. A high proportion of individuals with autism displayed absent or reduced behavioral pain reactivity at home (68.6%), at day-care (34.2%) and during venepuncture (55.6%). Despite their high rate of absent behavioral pain reactivity during venepuncture (41.3 vs. 8.7% of controls, P<0.0001), individuals with autism displayed a significantly increased heart rate in response to venepuncture (P<0.05). Moreover, this response (Delta heart rate) was significantly greater than for controls (mean+/-SEM; 6.4+/-2.5 vs. 1.3+/-0.8 beats/min, P<0.05). Plasma beta-endorphin levels were higher in the autistic group (P<0.001) and were positively associated with autism severity (P<0.001) and heart rate before or after venepuncture (P<0.05), but not with behavioral pain reactivity. CONCLUSIONS/SIGNIFICANCE:The greater heart rate response to venepuncture and the elevated plasma beta-endorphin found in individuals with autism reflect enhanced physiological and biological stress responses that are dissociated from observable emotional and behavioral reactions. The results suggest strongly that prior reports of reduced pain sensitivity in autism are related to a different mode of pain expression rather than to an insensitivity or endogenous analgesia, and do not support opioid theories of autism. Clinical care practice and hypotheses regarding underlying mechanisms need to assume that children with autism are sensitive to pain.http://europepmc.org/articles/PMC2728512?pdf=render
spellingShingle Sylvie Tordjman
George M Anderson
Michel Botbol
Sylvie Brailly-Tabard
Fernando Perez-Diaz
Rozenn Graignic
Michèle Carlier
Gérard Schmit
Anne-Catherine Rolland
Olivier Bonnot
Séverine Trabado
Pierre Roubertoux
Guillaume Bronsard
Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
PLoS ONE
title Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
title_full Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
title_fullStr Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
title_full_unstemmed Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
title_short Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.
title_sort pain reactivity and plasma beta endorphin in children and adolescents with autistic disorder
url http://europepmc.org/articles/PMC2728512?pdf=render
work_keys_str_mv AT sylvietordjman painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT georgemanderson painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT michelbotbol painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT sylviebraillytabard painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT fernandoperezdiaz painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT rozenngraignic painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT michelecarlier painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT gerardschmit painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT annecatherinerolland painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT olivierbonnot painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT severinetrabado painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT pierreroubertoux painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder
AT guillaumebronsard painreactivityandplasmabetaendorphininchildrenandadolescentswithautisticdisorder